You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Astrocyte Expression of Major Histocompatibility Complex Gene Products in Multiple Sclerosis Brain Tissue Obtained by Stereotactic Biopsy

Richard M. Ransohoff, MD; Melinda L. Estes, MD

Arch Neurol. 1991;48(12):1244-1246.


Abstract

• Major histocompatibility complex (MHC) class I and class II antigens were characterized by immunocytochemistry in two chronic-active multiple sclerosis lesions in tissue obtained from two patients by stereotactic biopsy. We examined in particular astrocytic MHC-positive cells in relation to lesion architecture. The MHC class I (HLA-A,B,C)—positive astrocytic cells were widely dispersed, being present at the lesion edge, in the gliotic lesion center, and in normal-appearing white matter as well. Morphologically astrocytic MHC class II (HLA-DR)—positive cells were confined exclusively to the lesion edge. By staining serial sections with antisera to glialfibrillary acidic protein and HLA-DR, we confirmed the lineage of several MHC class II—positive astrocytes. The demonstration of MHC antigen—positive astrocytes in multiple sclerosis tissue obtained by stereotactic biopsy is novel; the differential distribution of MHC class I—and class II—positive astrocytes in the multiple sclerosis lesion may provide suggestive clues about the regulation of MHC expression on these cells in vivo.



Author Affiliations

From the Departments of Molecular Biology and Neurology and the Mellen Center for Multiple Sclerosis Treatment and Research (Dr Ransohoff) and the Departments of Pathology and Neurology (Dr Estes), The Research Institute, Cleveland, Ohio.


Footnotes

Accepted for publication April 23, 1991.

Reprint requests to the Department of Molecular Biology, NC2, The Research Institute, Cleveland Clinic Foundation, One Clinic Center, 9500 Euclid Ave, Cleveland, OH 44195-5178 (Dr Ransohoff).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Friese and Fugger
Brain 2005;128:1747-1763.
ABSTRACT | FULL TEXT  

Are Astrocytes Central Players in the Pathophysiology of Multiple Sclerosis?
De Keyser et al.
Arch Neurol 2003;60:132-136.
ABSTRACT | FULL TEXT  

Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors
De Keyser et al.
Neurology 1999;53:1628-1628.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.